Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2018 16:00 ET | Source: Amyris, Inc.

Amyris Continues Strong Momentum and Execution with 77% Revenue Growth and Exceeds Gross Margin Target

Q1 2018 GAAP revenue of $23.0 million, compared with GAAP revenue of $13.0 million for Q1 2017, representing 77% growth over first quarter of 2017.Q1 2018 Non-GAAP gross margin of $19.0 million, or...
May 10, 2018 08:30 ET | Source: Amyris, Inc.

Amyris to Participate in Upcoming Investor Conferences

EMERYVILLE, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it plans to participate in the following upcoming investor...
May 09, 2018 08:30 ET | Source: Amyris, Inc.

Amyris Presents Its No Compromise™ Product Portfolio at Techonomy New York

EMERYVILLE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, will be presenting its portfolio of commercialized products at Techonomy New York...
May 08, 2018 13:05 ET | Source: Amyris, Inc.

Amyris to Announce First Quarter 2018 Financial Results on Monday, May 14, 2018

EMERYVILLE, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the first quarter ended March 31, 2018 after market close on Monday, May 14, 2018. ...
May 03, 2018 08:30 ET | Source: Amyris, Inc.

Amyris Collaborates with Firmenich to Develop Disruptive Bio-Based Fragrance Ingredient

EMERYVILLE, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it successfully collaborated with its fragrance partner,...
April 03, 2018 08:30 ET | Source: Amyris, Inc.

Amyris to Present at H.C. Wainwright Global Life Sciences Investment Conference on April 9, 2018

EMERYVILLE, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that management will be presenting at the H.C. Wainwright Global...
March 15, 2018 16:00 ET | Source: Amyris, Inc.

Amyris Reports Another Strong Quarter with Solid Operating Performance and 2017 Revenue of $143.4 Million up 113% over 2016

Q4 2017 GAAP revenue of $80.6 million, compared with GAAP revenue of $22.2 million for Q4 2016 Q4 2017 operating income of $33.0 million compared with Q4 2016 operating loss of $34.5 millionQ4 2017...
February 26, 2018 08:30 ET | Source: Amyris, Inc.

Amyris to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, March 15, 2018

EMERYVILLE, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the fourth quarter and fiscal year ended December 31, 2017 after market close on...
February 08, 2018 08:30 ET | Source: Amyris, Inc.

Amyris Aprinnova Joint Venture Launches Pharmaceutical Grade Neossance Squalane USP – Opens New Market Among FDA Regulated Products

EMERYVILLE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that Aprinnova, its joint venture with NIKKOL GROUP (“NIKKOL”),...
February 01, 2018 08:30 ET | Source: Amyris, Inc.

Amyris Biossance Starts 2018 with Over 300% Retail Sales Growth – Now Available Across SEPHORA Canada Stores

EMERYVILLE, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Biossance™, the consumer beauty brand from Amyris, Inc. (NASDAQ:AMRS), today announced its innovative line of clean beauty products will be...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right